Biotech

All Articles

Bayer markers $547M contract to push boundaries of noncoding RNA

.Bayer executives were keen to stress to Tough this summer season that the German pharma giant's hun...

UK introduces plannings to launch 18 new clinical trial hubs

.Among a yearslong medical test downtrend in the U.K., a brand new public-private relationship has a...

UPDATE: Genentech telegrams 93 layoffs in California after discussing programs to shutter cancer immunology analysis device

.Following the announcement of a large cutback round in April as well as a primary rebuilding campai...

Neurocrine's KarXT rival strikes in period 2-- however just at low dosage

.Neurocrine Biosciences has accomplished its hoped-for account in a phase 2 schizophrenia trial, pro...

Vaderis' unusual blood vessel disorder medicine decreases nosebleeds

.Vaderis Therapeutics' objective to develop the very first drug striven exclusively at a certain unu...

Navigator increases $100M to develop new autoimmune pipe

.Sat nav Medicines has equipped on its own with $100 thousand in set A funds as the youthful biotech...

Duality looks for money for ADC trials as IPO wave spreads to Asia

.China's Duplicity Biotherapeutics has filed (PDF) documentation for a Hong Kong IPO, finding an unr...

YolTech markets China liberties to genetics modifying therapy for $29M

.4 months after Mandarin genetics editing firm YolTech Therapeutics took its cholesterol disease-foc...

Addex sell increases after Indivior offers up to $300M for material

.Indivior is actually getting a small molecule allosteric modulator designed to address drug make us...

Molecular Partners adjusts AML trial over 'suboptimal direct exposure'

.Molecular Companions has determined "suboptimal exposure" to its own tetra-specific T-cell engager ...